NFCR Writer David Perry, Author at NFCR - Page 2 of 10

NFCR Writer David Perry

New Combination Therapy Improves Pancreatic Cancer Survival

A new combination of two standing drugs and radiation therapy has the potential to revolutionize the treatment and care of pancreatic cancer, one of the most lethal diagnoses an oncologist can face with patients. Using data from studies by NFCR fellow Dr. Rakesh Jain, investigators at Massachusetts General Hospital used…...

Read more

Brian Leyland-Jones: Now Is the Time!

“This is the transformative time in oncology,” heralds Brian Leyland-Jones, M.B., B.S., Ph.D., and there is no spin doctoring in the statement by the member of the National Foundation for Cancer Research’s scientific advisory board. From genomics to targeted therapies to vaccinations, the last 40 years has seen more strides…...

Read more

Dr. Webster Cavenee: Oddball Ideas

When Dr. Webster “Web” Cavenee first introduced the idea of genetic tumor suppressors in 1982, it took to the air like a lead balloon. “I got a lot of blank looks,” he recalls. “A lot of angry ones, too.” How times change. Tumor suppressor genes, also called antioncogenes, are now…...

Read more

Breakthrough: Dr. César Milstein And The MAbs

They are called “mAbs,” short for monoclonal antibodies, and they are a big deal in oncology. One of the immune systems most elegant soldiers, mAbs are formed by B cells, a type of white blood cell produced in the spleen, in response to specific foreign invaders (real and perceived) known…...

Read more

Sarcoma Origin Identified

Cancer is anything but a straightforward disease; one tumor type can be entirely different from another not only in location, but causal agent and origin. There is differentiation even within the same type of cancer. Take sarcoma, which is in fact an umbrella term for nearly 100 cancers originating in…...

Read more

For Young Adults, “Cancer Recovery” Is A Loaded Term

Despite all of the advancements in cancer research and cures, there is one major aspect of the disease that is as under-discussed as it is controversial: patient cost. While the road to recovery is anything but easy, the road to post-cancer financial wellness is a hotly-contested and complex issue that…...

Read more

Origin Cells of Glioblastoma May Have Been Identified

In what could be a major breakthrough, scientists at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea claim to have identified the cellular origin of glioblastoma, a fast-growing type of central nervous system tumor that forms from supportive tissue of the brain and spinal cord. It…...

Read more

At Its Root

Chaos can be surprisingly orderly. While cancer is characterized by uncontrolled cell growth, that growth is, nevertheless, the result of a very particular cascade of events, from carcinogen exposure to genetic mutations. Interfere with that cascade, and cancer can be ground to a halt, or even killed off. The efforts…...

Read more

New Therapies Aim to Lessen Side Effects in Children

Ask any parent about their child fighting cancer and words like “nightmare” and “helpless” will almost certainly be part of the conversation. Within pediatric cancer medicine, the entire field faces the brutal reality that chemotherapy, surgery and most other cancer treatments are not designed for children. This can be somewhat…...

Read more

Ronald DePinho: The Age of Cancer

“For me, this is one of the great honors of my research career,” says Dr. Ronald DePinho, who in 2009 won the prestigious Szent-Györgyi Prize for Progress in Cancer Research—and who has a touching personal tie to the namesake of the accolade. “I had the privilege of meeting Dr. Szent-Györgyi…...

Read more